Routine serologic testing for hepatitis C virus infection should be instituted among dialysis patients
- PMID: 11130264
- DOI: 10.1046/j.1525-139x.2000.00108.x
Routine serologic testing for hepatitis C virus infection should be instituted among dialysis patients
Abstract
Since the cloning of hepatitis C virus (HCV), a number of serologic and virologic tests for detecting infections with this virus have been made available for clinical practice. This led to the recognition of HCV as a major health hazard in hemodialysis (HD) centers. Yet the nephrology community has not been offered explicit recommendations about routine serologic testing for HCV of dialysis patients and consequently has remained unclear and divided about the utility of this testing. This review presents evidence in support of instituting routine serologic testing for HCV among dialysis patients. It concludes that because of the peculiar features of HCV infection in HD patients, serologic testing for HCV is the only means for unequivocal diagnosis of hepatitis C and an irreplaceable instrument for monitoring the incidence and the prevalence of the infection in this population. Serologic surveillance for HCV infection is crucial for identifying the association of new cases of HCV infection with potential risk factors for HCV transmission, particularly nosocomial, that can be modified in a way to prevent further dissemination of the virus. Data collected from routine serologic testing for HCV will undoubtedly improve our understanding of the epidemiology of HCV in the dialysis population and will provide a strong foundation for developing preventive measures and infection control strategies that are highly effective in controlling HCV infection. Routine serologic testing for HCV is also of direct benefit to the individual patient since establishing the HCV serologic status of each patient is important for optimizing patient care.
Similar articles
-
Hepatitis C virus in chronic dialysis patients.Minerva Urol Nefrol. 2005 Sep;57(3):175-97. Minerva Urol Nefrol. 2005. PMID: 15986016 Review.
-
Hepatitis C screening strategies in hemodialysis patients.Am J Kidney Dis. 2001 Jul;38(1):91-7. doi: 10.1053/ajkd.2001.25199. Am J Kidney Dis. 2001. PMID: 11431187
-
Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric French survey.Nephrol Dial Transplant. 2011 Jul;26(7):2309-16. doi: 10.1093/ndt/gfq696. Epub 2010 Nov 19. Nephrol Dial Transplant. 2011. PMID: 21097646
-
Acquisition of hepatitis C virus in hemodialysis patients: a prospective study by branched DNA signal amplification assay.Am J Kidney Dis. 1998 Apr;31(4):647-54. doi: 10.1053/ajkd.1998.v31.pm9531181. Am J Kidney Dis. 1998. PMID: 9531181
-
Prevention of hepatitis B virus and hepatitis C virus transmission in hemodialysis centers: review of current international recommendations.Arab J Nephrol Transplant. 2011 Jan;4(1):35-47. doi: 10.4314/ajnt.v4i1.63154. Arab J Nephrol Transplant. 2011. PMID: 21469594 Review.
Cited by
-
Hepatitis C infection in dialysis patients: a link to poor clinical outcome?Int Urol Nephrol. 2007;39(1):247-59. doi: 10.1007/s11255-006-9075-8. Epub 2006 Sep 29. Int Urol Nephrol. 2007. PMID: 17009087 Review.
-
Viral hepatitis in hemodialysis: An update.J Transl Int Med. 2015 Jun-Sep;3(3):93-105. doi: 10.1515/jtim-2015-0018. Epub 2015 Sep 30. J Transl Int Med. 2015. PMID: 27847896 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical